Skip to main content

Animations

MJFF Publications

2976 - 3000 of 8459 Results
Title
Year
  • Year
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • Summary Details
    OPEN
    Title: The Hsc70 disaggregation machinery removes monomer units directly from α-synuclein fibril ends
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-021-25966-w
    Citation Count: 58
  • Summary Details
    OPEN
    Title: Validation and clinical value of the MANAGE-PD tool: A clinician-reported tool to identify Parkinson's disease patients inadequately controlled on oral medications
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.10.009
    Citation Count: 39
  • Summary Details
    OPEN
    Title: Walking on common ground: a cross-disciplinary scoping review on the clinical utility of digital mobility outcomes
    Journal Name: npj Digital Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41746-021-00513-5
    Citation Count: 76
  • Summary Details
    OPEN
    Title: Generation of two human induced pluripotent stem cell lines from fibroblasts of unrelated Parkinson’s patients carrying the G2019S mutation in the LRRK2 gene (LCSBi005, LCSBi006)
    Journal Name: Stem Cell Research
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.scr.2021.102569
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Lower Circulating Lymphocyte Count Predicts ApoEε4‐Related Cognitive Decline in Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.28799
    Citation Count: 12
  • Summary Details
    RESTRICTED
    Title: Parkinson's Disease and Type 2 Diabetes: HbA1c Is Associated with Motor and Cognitive Severity
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28829
    Best OA location URL:
    Citation Count: 8
  • Summary Details
    OPEN
    Title: T lymphocyte senescence is attenuated in Parkinson’s disease
    Journal Name: Journal of Neuroinflammation
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1186/s12974-021-02287-9
    Citation Count: 29
  • Summary Details
    RESTRICTED
    Title: A Summary of Phenotypes Observed in the In Vivo Rodent Alpha-Synuclein Preformed Fibril Model
    Journal Name: Journal of Parkinson's Disease
    Publisher: IOS Press
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.3233/jpd-212847
    Citation Count: 22
  • Summary Details
    RESTRICTED
    Title: Exploring the Use of Intracranial and Extracranial (Remote) Photobiomodulation Devices in Parkinson’s Disease: A Comparison of Direct and Indirect Systemic Stimulations
    Journal Name: Journal of Alzheimer's Disease
    Publisher: IOS Press
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.3233/jad-210052
    Best OA location URL:
    Citation Count: 20
  • Summary Details
    OPEN
    Title: Predicting PY motif-mediated protein-protein interactions in the Nedd4 family of ubiquitin ligases
    Journal Name: PLOS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0258315
    Citation Count: 15
  • Summary Details
    OPEN
    Title: A Novel Variant of ATP5MC3 Associated with Both Dystonia and Spastic Paraplegia
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28821
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Lack of progression of beta dynamics after long‐term subthalamic neurostimulation
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/acn3.51463
    Citation Count: 24
  • Summary Details
    OPEN
    Title: Mendelian Randomisation Study of Smoking, Alcohol, and Coffee Drinking in Relation to Parkinson’s Disease
    Journal Name: Journal of Parkinson's Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.3233/jpd-212851
    Citation Count: 46
  • Summary Details
    RESTRICTED
    Title: Antimuscarinic Anticholinergic Medications in Parkinson Disease: To Prescribe or Deprescribe?
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mdc3.13347
    Citation Count: 19
  • Summary Details
    OPEN
    Title: Early subthalamic nucleus deep brain stimulation in Parkinson’s disease reduces long-term medication costs
    Journal Name: Clinical Neurology and Neurosurgery
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.clineuro.2021.106976
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Modeling alpha-synuclein pathology in a human brain-chip to assess blood-brain barrier disruption
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-021-26066-5
    Citation Count: 164
  • Summary Details
    RESTRICTED
    Title: Platelet Behavior Contributes to Neuropathologies: A Focus on Alzheimer's and Parkinson's Disease
    Journal Name: Seminars in Thrombosis and Hemostasis
    Publisher: Georg Thieme Verlag KG
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1055/s-0041-1733960
    Best OA location URL:
    Citation Count: 5
  • Summary Details
    RESTRICTED
    Title: Population-specific neuromodulation prolongs therapeutic benefits of deep brain stimulation
    Journal Name: Science
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1126/science.abi7852
    Citation Count: 122
  • Summary Details
    RESTRICTED
    Title: Visual dysfunction is associated with cognitive impairment in Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.10.005
    Best OA location URL:
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Biomarkers of neurodegeneration and glial activation validated in Alzheimer’s disease assessed in longitudinal cerebrospinal fluid samples of Parkinson’s disease
    Journal Name: PLOS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0257372
    Citation Count: 35
  • Summary Details
    OPEN
    Title: Direct targeting of wild-type glucocerebrosidase by antipsychotic quetiapine improves pathogenic phenotypes in Parkinson’s disease models
    Journal Name: JCI Insight
    Publisher: American Society for Clinical Investigation
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1172/jci.insight.148649
    Citation Count: 7
  • Summary Details
    RESTRICTED
    Title: New Insights from a Two-Country Study Comparing Escalation Strategies for MS Drugs
    Journal Name: Neurology Today
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1097/01.nt.0000797988.61856.80
    Best OA location URL:
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Then and Now: 20 Years of Monumental Strides in Movement Disorders
    Journal Name: Neurology Today
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1097/01.nt.0000797984.85450.f1
    Best OA location URL:
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Apolipoprotein E Genotype Contributes to Motor Progression in Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28805
    Best OA location URL:
    Citation Count: 27
  • Summary Details
    OPEN
    Title: Brain injections of glial cytoplasmic inclusions induce a multiple system atrophy-like pathology
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awab374
    Citation Count: 20
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.